Ariana Hardy

723 total citations
4 papers, 29 citations indexed

About

Ariana Hardy is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Ariana Hardy has authored 4 papers receiving a total of 29 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 1 paper in Molecular Biology and 1 paper in Genetics. Recurrent topics in Ariana Hardy's work include Colorectal Cancer Treatments and Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Ariana Hardy is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Ariana Hardy collaborates with scholars based in United States. Ariana Hardy's co-authors include Nicole I. zur Nieden, Karolyn Morris, Blanca Ledezma, Paulina Linares, Carlos Adame, Amy L. Cummings, Jaklin Gukasyan, Paul Coluzzi, Linda M. Liau and Melody Mendenhall and has published in prestigious journals such as Journal of Clinical Oncology, Free Radical Biology and Medicine and Neuro-Oncology.

In The Last Decade

Ariana Hardy

4 papers receiving 29 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ariana Hardy United States	2	15	6	5	4	4	4	29
Stephanie Krauter United States	2	9 0.6×	5 0.8×	7 1.4×	3 0.8×	4 1.0×	2	31
Kristina Sorg United States	3	17 1.1×	3 0.5×	6 1.2×	6 1.5×	6 1.5×	5	34
Patrick Tomboc United States	3	7 0.5×	8 1.3×	8 1.6×	6 1.5×	6 1.5×	7	24
A. Nogueira-Rodrigues Brazil	2	12 0.8×	8 1.3×	4 0.8×	4 1.0×	2 0.5×	3	28
Julia E. Rudolph United States	4	10 0.7×	6 1.0×	7 1.4×	3 0.8×	6 1.5×	7	22
Gloryanne Aidoo-Micah United Kingdom	3	12 0.8×	9 1.5×	7 1.4×	5 1.3×	2 0.5×	4	25
Marie‐Louise Hoffknecht Germany	2	11 0.7×	5 0.8×	7 1.4×	3 0.8×	9 2.3×	2	37
Murtaza Malbari United States	1	13 0.9×	4 0.7×	4 0.8×	2 0.5×	7 1.8×	2	19
Yujing Xia United Kingdom	2	34 2.3×	3 0.5×	4 0.8×	3 0.8×	5 1.3×	2	44
Daisy D. Colón-López United States	3	19 1.3×	5 0.8×	3 0.6×	2 0.5×	4 1.0×	4	32

Countries citing papers authored by Ariana Hardy

Since Specialization

Citations

This map shows the geographic impact of Ariana Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariana Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariana Hardy more than expected).

Fields of papers citing papers by Ariana Hardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariana Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariana Hardy. The network helps show where Ariana Hardy may publish in the future.

Co-authorship network of co-authors of Ariana Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Ariana Hardy. A scholar is included among the top collaborators of Ariana Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariana Hardy. Ariana Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Hardy, Ariana, et al.. (2021). The FOXO signaling axis displays conjoined functions in redox homeostasis and stemness. Free Radical Biology and Medicine. 169. 224–237. 22 indexed citations

2.

Lisberg, Aaron, Amy L. Cummings, Jonathan W. Goldman, et al.. (2018). A phase II study of pembrolizumab in EGFR-mutant, PD-L1+, tyrosine kinase inhibitor (TKI) naïve patients with advanced NSCLC.. Journal of Clinical Oncology. 36(15_suppl). 9014–9014. 5 indexed citations

3.

Lisberg, Aaron, D. Andrew Tucker, Jonathan W. Goldman, et al.. (2017). P3.02c-083 Treatment Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center. Journal of Thoracic Oncology. 12(1). S1328–S1328. 1 indexed citations

4.

Hardy, Ariana, Robert M. Prins, Xiao–Tang Kong, et al.. (2014). NI-32 * ENHANCING TUMOR RESPONSE USING QUANTITATIVE VOLUMETRY FROM T1 SUBTRACTION MAPS IN MALIGNANT GLIOMA TREATED WITH DENDRITIC CELL VACCINATION. Neuro-Oncology. 16(suppl 5). v145–v145. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact